Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis
Recruiting · NCT07546552 · Registry updated 2026-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Relevance of Modifying RANKL Signaling During Folliculogenesis | Bone Diseases, Metabolic, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, bone disorder, female infertility, female reproductive system disorder, infertility disorder, metabolic disease, musculoskeletal system disorder, osteoporosis | Recruiting | Not applicable | 2026-04-22 | NCT07546552 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Herlev Hospital | 63 |
| Peter Humaidan | 2 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Regionshospitalet, Skive, Midt Jylland 7800 | Skive | Denmark | 1 |